Item request has been placed!
×
Item request cannot be made.
×

Processing Request
Item request has been placed!
×
Item request cannot be made.
×

Processing Request
-
Authors :
Su KY; School of Science, Monash University Malaysia, 47500, Subang Jaya, Selangor, Malaysia.; Department of Experimental Medical Science, Faculty of Medicine, Lund University, 22184, Lund, Sweden.
Subjects: Cisplatin*/Cisplatin*/Cisplatin*/pharmacology ; Autophagy*/Autophagy*/Autophagy*/drug effects ; Extracellular Vesicles*/Extracellular Vesicles*/Extracellular Vesicles*/metabolism
-
Source:
Scientific reports [Sci Rep] 2025 May 07; Vol. 15 (1), pp. 15945. Date of Electronic Publication: 2025 May 07.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:
تفاصيل العنوان
-
Source:
Biomarker Stratified CaboZantinib (NSC#761968) and NivOlumab (NSC#748726) (BiCaZO) - A Phase II Study of Combining Cabozantinib and Nivolumab in Participants With Advanced Solid Tumors (IO Refractory
تفاصيل العنوان
-
Source:
Enhanced Outcome Prediction in Cutaneous Squamous Cell Carcinoma Using Deep-learning and Computational Histopathology
تفاصيل العنوان
-
Source:
A Phase II Sequential Window of Opportunity Trial of Pembrolizumab + N-803 Alone or in Combination With PD-L1 t-haNK Cells for Resectable Head and Neck Squamous Cell
تفاصيل العنوان
-
Source:
Reduction in the Number of Chemotherapy Cycles in Combination With Pembrolizumab in First-line Treatment of PD-L1-positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinomas
تفاصيل العنوان